The neurologist from Cleveland Clinic discussed the challenges of treating progressive MS, and shared his clinical experience with ibudilast.
Robert Fox, MD
Advertisement
Staff neurologist, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic
Articles by Robert Fox, MD
The staff neurologist at Cleveland Clinic’s Mellen Center for Multiple Sclerosis spoke about the current understanding of the biomarker.
Advertisement
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis
2
Phase 3 VALOR Data Further Support Tofersen’s Impact on ALS Disease Progression, Survival
3
Patients Treated With REGENXBIO’s DMD Gene Therapy RGX-202 Exceed Expected Disease Trajectory on NSAA
4
Efficacy and Safety Data for Tavapadon as an Emerging Therapy in Parkinson’s Disease
5